Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Ligand Binding Sites02:40

Ligand Binding Sites

14.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
14.9K
Protein-protein Interfaces02:04

Protein-protein Interfaces

14.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.4K
Drug Discovery: Overview01:26

Drug Discovery: Overview

11.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.1K
Conserved Binding Sites01:49

Conserved Binding Sites

5.0K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
5.0K
Predicting Molecular Geometry02:27

Predicting Molecular Geometry

45.3K
VSEPR Theory for Determination of Electron Pair Geometries
45.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

SynCraft: an integrated web server for ADMET-aware retrosynthesis and molecular design.

Nucleic acids research·2026
Same author

TwistDAN: Twisted Domain Adversarial Network for Synthetic Accessibility Assessment.

Journal of chemical information and modeling·2026
Same author

Partner-RBR: Predicting Multitype RNA-Binding Residues Based on Mutual Learning.

Journal of chemical information and modeling·2025
Same author

Precise prediction of hotspot residues in protein-RNA complexes using graph attention networks and pretrained protein language models.

Bioinformatics (Oxford, England)·2025
Same author

DeepHeteroCDA: circRNA-drug sensitivity associations prediction via multi-scale heterogeneous network and graph attention mechanism.

Briefings in bioinformatics·2025
Same author

DeepRSMA: a cross-fusion-based deep learning method for RNA-small molecule binding affinity prediction.

Bioinformatics (Oxford, England)·2024

相关实验视频

Updated: Jan 17, 2026

A Protocol for Computer-Based Protein Structure and Function Prediction
16:41

A Protocol for Computer-Based Protein Structure and Function Prediction

Published on: November 3, 2011

69.7K

DeepExpDR:通过分子拓分组和基础结构意识的专家预测药物反应.

Yuanpeng Zhang1, Zhijian Huang2, Yurong Qian1

  • 1School of Software, Xinjiang University, 830046 Urumqi, China.

Journal of chemical information and modeling
|September 22, 2025
PubMed
概括

DeepExpDR是一个新的深度学习框架,通过整合分子拓和基因表达,准确地预测抗癌药物反应. 这种方法通过克服传统实验方法的局限性,提高了精准医学.

更多相关视频

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.7K
Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

949

相关实验视频

Last Updated: Jan 17, 2026

A Protocol for Computer-Based Protein Structure and Function Prediction
16:41

A Protocol for Computer-Based Protein Structure and Function Prediction

Published on: November 3, 2011

69.7K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.7K
Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

949

科学领域:

  • 计算生物学 计算生物学
  • 药物发现 药物发现 药物发现
  • 在瘤学中使用人工智能

背景情况:

  • 瘤异质性使癌症治疗和药物反应预测复杂化.
  • 目前用于验证药物反应的实验方法耗时且昂贵.
  • 现有的深度学习模型在药物反应预测中经常忽视分子拓性质.

研究的目的:

  • 开发DeepExpDR,这是一个深度专家框架,用于准确预测药物反应.
  • 将分子拓特征纳入药物反应预测模型.
  • 提高抗癌药物开发和精准医学的效率和有效性.

主要方法:

  • 预训练一个自我监督的集群模型,通过分子支架相似性将药物分组起来.
  • 将药物组分配给专门的基础结构意识专家.
  • 利用集成分子拓,基因表达和药物反应相关性矩阵的亚结构传感网络来预测IC50值.

主要成果:

  • 对于回归和分类任务,DeepExpDR在温暖和寒冷的环境中实现了最先进的性能.
  • 该框架通过一个案例研究证明了其在预测未知的癌症药物反应方面的有效性.
  • 实验结果验证了模型利用分子亚结构信息的能力.

结论:

  • DeepExpDR提供了一种强大的计算方法来预测药物反应,其性能优于现有的方法.
  • 该框架考虑分子拓学的能力提高了药物特征提取和预测准确度.
  • DeepExpDR促进了精密医学的进步,并加速了抗癌药物的发现.